UNITHROID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Unithroid, and when can generic versions of Unithroid launch?
Unithroid is a drug marketed by Stevens J and is included in one NDA.
The generic ingredient in UNITHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Unithroid
A generic version of UNITHROID was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for UNITHROID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,726 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for UNITHROID |
| Drug Sales Revenues: | Drug sales revenues for UNITHROID |
| What excipients (inactive ingredients) are in UNITHROID? | UNITHROID excipients list |
| DailyMed Link: | UNITHROID at DailyMed |
Recent Clinical Trials for UNITHROID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A |
| Children's Hospital of Philadelphia | N/A |
| Harvard University | N/A |
Pharmacology for UNITHROID
| Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for UNITHROID
US Patents and Regulatory Information for UNITHROID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stevens J | UNITHROID | levothyroxine sodium | TABLET;ORAL | 021210-001 | Aug 21, 2000 | AB1,AB2,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Stevens J | UNITHROID | levothyroxine sodium | TABLET;ORAL | 021210-007 | Aug 21, 2000 | AB1,AB2,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Stevens J | UNITHROID | levothyroxine sodium | TABLET;ORAL | 021210-004 | Aug 21, 2000 | AB1,AB2,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Stevens J | UNITHROID | levothyroxine sodium | TABLET;ORAL | 021210-011 | Aug 21, 2000 | AB1,AB2,AB3 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Stevens J | UNITHROID | levothyroxine sodium | TABLET;ORAL | 021210-012 | Feb 8, 2008 | AB1,AB2,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
